Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,476.21 846.22 211.10 -194.54 36.11 0.00 18.6953 -0.40 -1.1019 -24.7684 -0.09 -0.09 7.2420 - -
Maximum - - - - - - 475,026.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Akero Therapeutics, Inc. AKRO 34.45 -0.42 -1.20% 791 vs. 505 2,391.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
Apellis Pharmaceuticals, Inc. APLS 29.98 1.24 4.31% 4,070 vs. 2,360 3,650.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 121.00
Nuvalent, Inc. NUVL 95.42 1.33 1.41% 251 vs. 514 6,660.00 0.00 -44.00 -36.00 -330.00 -0.6900 -27.7942 0.0000 0.0000 0.0000 -0.0659 -0.0628 20.6970 69.00
Bio-Techne Corporation TECH 75.96 -0.38 -0.50% 614 vs. 852 12,050.00 303.00 49.00 64.00 1,297.00 0.3100 55.6413 0.0012 0.6764 0.1617 0.0244 0.0180 2.4910 158.00
DICE Therapeutics, Inc. DICE 47.55 0.03 0.06% 4,332 vs. 1,753 2,270.00 0.00 -34.00 -30.00 -248.00 -0.7400 -15.7831 0.0000 0.0000 0.0000 -0.0671 -0.0632 25.6858 47.00
BioMarin Pharmaceutical Inc. BMRN 67.07 0.13 0.19% 942 vs. 1,768 12,782.00 648.00 88.00 12.00 -532.00 0.4700 46.3847 0.0000 0.7850 0.1366 0.0175 0.0129 1.5477 190.00
Vaxcyte, Inc. PCVX 106.67 3.97 3.87% 871 vs. 965 12,992.00 0.00 -95.00 -171.00 -1,019.00 -0.8500 -19.6094 0.0000 0.0000 0.0000 -0.0479 -0.0454 17.2498 121.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for PCVX and its peers to uncover potential buy and sell opportunities.